Clinical trials
Terminated Phase 1/2 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 8 |
| 2016 | 2 |
| 2017 | 11 |
| 2018 | 5 |
| 2019 | 14 |
| 2020 | 12 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 109 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Hoffmann-La Roche | 5 |
| Wave Life Sciences USA, Inc. | 4 |
| Bristol-Myers Squibb | 3 |
| Incyte Corporation | 3 |
| Merck Sharp & Dohme LLC | 3 |
| RHEACELL GmbH & Co. KG | 3 |
| BioNTech SE | 2 |
| Gilead Sciences | 2 |
| Spur Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 9 |
| Recurrence | 9 |
| Leukemia, Myeloid, Acute | 8 |
| Leukemia | 6 |
| Lymphoma | 6 |
| Melanoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Huntington Disease | 4 |
| Lymphoma, B-Cell | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
Trials
Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.